Gaucher's disease historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Gaucher's disease}} | {{Gaucher's disease}} | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | ||
| Line 15: | Line 13: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 18:59, 21 August 2012
|
Gaucher's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gaucher's disease historical perspective On the Web |
|
American Roentgen Ray Society Images of Gaucher's disease historical perspective |
|
Risk calculators and risk factors for Gaucher's disease historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
Historical Perspective
Gaucher's disease is named after the French doctor Philippe Gaucher who originally described it in 1882.
Philippe Gaucher described the disease in his doctoral thesis in 1882.[1] The biochemical basis for the disease would be elucidated in 1965 by Brady et al.[2]
References
- ↑ Gaucher PCE. De l'epithelioma primitif de la rate, hypertrophie idiopathique de la rate sans leucemie. Academic thesis, Paris, France, 1882.
- ↑ Brady RO, Kanfer JN, Shapiro D (1965). "Metabolism of glucocerebrosides. II. Evidence of an enzymatic deficiency in Gaucher's disease". Biochem. Biophys. Res. Commun. 18: 221–5. PMID 14282020.